HEADER HYDROLASE/HYDROLASE INHIBITOR 27-JUL-05 2BXT TITLE DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS WITH A TITLE 2 SOLUBILIZING CATIONIC P1-P2-LINKER COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA THROMBIN; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: LARGE SUBUNIT, RESIDUES 364-622; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HIRUDIN VARIANT-2; COMPND 10 CHAIN: I; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: ALPHA THROMBIN; COMPND 14 CHAIN: L; COMPND 15 FRAGMENT: SMALL SUBUNIT, RESIDUES 328-363; COMPND 16 SYNONYM: COAGULATION FACTOR II; COMPND 17 EC: 3.4.21.5; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 10 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 11 ORGANISM_TAXID: 6421; SOURCE 12 MOL_ID: 3; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.BULAT,S.BOSIO,E.GRABOWSKI,M.A.PAPADOPOULOS,S.CEREZO-GALVEZ, AUTHOR 2 C.ROSENBAUM,V.G.MATASSA,I.OTT,G.METZ,J.SCHAMBERGER,R.SEKUL,A.FEURER REVDAT 4 21-DEC-16 2BXT 1 COMPND SOURCE DBREF REVDAT 3 13-JUL-11 2BXT 1 VERSN REVDAT 2 24-FEB-09 2BXT 1 VERSN REVDAT 1 26-OCT-06 2BXT 0 JRNL AUTH S.BULAT,S.BOSIO,M.A.PAPADOPOULOS,S.CEREZO-GALVEZ, JRNL AUTH 2 E.GRABOWSKI,C.ROSENBAUM,V.G.MATASSA,I.OTT,G.METZ, JRNL AUTH 3 J.SCHAMBERGER,R.SEKUL,A.FEURER JRNL TITL DESIGN AND DISCOVERY OF NOVEL, POTENT PYRAZINONE-BASED JRNL TITL 2 THROMBIN INHIBITORS WITH A SOLUBILIZING P1-P2-LINKER JRNL REF LETT.DRUG DES.DISCOVERY V. 3 289 2006 JRNL REFN ISSN 1570-1808 JRNL DOI 10.2174/157018006777574203 REMARK 2 REMARK 2 RESOLUTION. 1.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 31095 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2488 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2358 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.07400 REMARK 3 B22 (A**2) : 0.10400 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.08100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 45.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN-ALLHDG.PARAM REMARK 3 TOPOLOGY FILE 1 : INH.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BXT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JUL-05. REMARK 100 THE PDBE ID CODE IS EBI-24716. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31095 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.25250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.95850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.25250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.95850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR H 149 REMARK 465 ALA H 149A REMARK 465 ASN H 149B REMARK 465 VAL H 149C REMARK 465 GLY H 149D REMARK 465 GLU H 247 REMARK 465 THR L -5 REMARK 465 PHE L -4 REMARK 465 GLY L -3 REMARK 465 SER L -2 REMARK 465 GLY L -1 REMARK 465 GLU L 0A REMARK 465 GLY L 16 REMARK 465 ARG L 17 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP H 148 CA C O CB CG CD1 CD2 REMARK 470 TRP H 148 NE1 CE2 CE3 CZ2 CZ3 CH2 REMARK 470 GLY H 246 CA C O REMARK 470 ASP L 15 CA C O CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR H 60A 81.30 -154.25 REMARK 500 ASN H 60G 82.71 -155.20 REMARK 500 HIS H 71 -60.95 -125.62 REMARK 500 ILE H 79 -64.70 -128.77 REMARK 500 GLU H 97A -72.72 -116.04 REMARK 500 THR H 147 -90.02 -115.79 REMARK 500 PHE L 7 -84.04 -129.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "HB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C2D H 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF HIRUDIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A2C RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A REMARK 900 BLUE-GREEN ALGA REMARK 900 RELATED ID: 1A3B RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL REMARK 900 BORONATE INHIBITOR BOROLOG1 REMARK 900 RELATED ID: 1A3E RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL REMARK 900 BORONATE INHIBITOR BOROLOG2 REMARK 900 RELATED ID: 1A46 RELATED DB: PDB REMARK 900 THROMBIN COMPLEXED WITH HIRUGEN AND A BETA- STRAND MIMETIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1A4W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE- CONTAINING REMARK 900 INHIBITORS: PROBES OF THE S1' BINDING SITE REMARK 900 RELATED ID: 1A5G RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE REMARK 900 MIMETIC INHIBITOR AND HIRUGEN REMARK 900 RELATED ID: 1A61 RELATED DB: PDB REMARK 900 THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1ABI RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULOG 3 REMARK 900 RELATED ID: 1ABJ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG REMARK 900 CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED REMARK 900 BY A METHYLENE GROUP REMARK 900 RELATED ID: 1AD8 RELATED DB: PDB REMARK 900 COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL REMARK 900 P1 MOIETY REMARK 900 RELATED ID: 1AE8 RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D- PHE-PRO-AZALYS-ONP REMARK 900 RELATED ID: 1AFE RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO- AZALYS-ONP REMARK 900 RELATED ID: 1AHT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: REMARK 900 3.4.21.5; MOL_ID: 2; MOLECULE: HIRUGEN; CHAIN: I; REMARK 900 HETEROGEN: P- AMIDINO-PHENYL-PYRUVATE REMARK 900 RELATED ID: 1AI8 RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE REMARK 900 INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA- REMARK 900 PRO-BOROMPG REMARK 900 RELATED ID: 1AIX RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR REMARK 900 HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL REMARK 900 RELATED ID: 1AWF RELATED DB: PDB REMARK 900 NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT REMARK 900 RELATED ID: 1AWH RELATED DB: PDB REMARK 900 NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT REMARK 900 RELATED ID: 1AY6 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED REMARK 900 MACROCYCLIC TRIPEPTIDE MOTIF REMARK 900 RELATED ID: 1B5G RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE REMARK 900 MIMETIC INHIBITOR AND HIRUGEN REMARK 900 RELATED ID: 1B7X RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D- REMARK 900 PHE-PRO-ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 1BA8 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1BB0 RELATED DB: PDB REMARK 900 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1BCU RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN REMARK 900 RELATED ID: 1BHX RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH REMARK 900 THE INHIBITOR SDZ 229- 357 REMARK 900 RELATED ID: 1BMM RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-4- REMARK 900 [(AMINOIMINOMETHYL)AMINO]-N-[[1-[3- HYDROXY-2-[(2- REMARK 900 NAPHTHALENYLSULFONYL)AMINO]-1- OXOPROPYL]-2-PYRROLIDINYL] REMARK 900 METHYL]BUTANAMIDE (BMS-186282) REMARK 900 RELATED ID: 1BMN RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-1- REMARK 900 (AMINOIMINOMETHYL)-N-[[1-[N-[(2- NAPHTHALENYLSULFONYL)-L- REMARK 900 SERYL]-PYRROLIDINYL] METHYL]-3-PIPERIDENECARBOXAMIDE (BMS- REMARK 900 189090) REMARK 900 RELATED ID: 1BTH RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC REMARK 900 TRYPSIN INHIBITOR REMARK 900 RELATED ID: 1C1U RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF REMARK 900 SERINE PROTEASES REMARK 900 RELATED ID: 1C1V RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF REMARK 900 SERINE PROTEASES REMARK 900 RELATED ID: 1C1W RELATED DB: PDB REMARK 900 RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF REMARK 900 SERINE PROTEASES REMARK 900 RELATED ID: 1C4U RELATED DB: PDB REMARK 900 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH REMARK 900 CYCLOHEXYL MOIETIES. REMARK 900 RELATED ID: 1C4V RELATED DB: PDB REMARK 900 SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH REMARK 900 CYCLOHEXYL MOIETIES. REMARK 900 RELATED ID: 1C4Y RELATED DB: PDB REMARK 900 SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS REMARK 900 RELATED ID: 1C5L RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- REMARK 900 BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE REMARK 900 PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1C5N RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- REMARK 900 BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE REMARK 900 PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1C5O RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- REMARK 900 BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE REMARK 900 PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1CA8 RELATED DB: PDB REMARK 900 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES REMARK 900 RELATED ID: 1D3D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH REMARK 900 BENZOTHIOPHENE INHIBITOR 4 REMARK 900 RELATED ID: 1D3P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH REMARK 900 BENZO[B]THIOPHENE INHIBITOR 3 REMARK 900 RELATED ID: 1D3Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH REMARK 900 BENZO[B]THIOPHENE INHIBITOR 2 REMARK 900 RELATED ID: 1D3T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH REMARK 900 BENZO[B]THIOPHENE INHIBITOR 1 REMARK 900 RELATED ID: 1D4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH REMARK 900 5- AMIDINOINDOLE-4- BENZYLPIPERIDINE INHIBITOR REMARK 900 RELATED ID: 1D6W RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- REMARK 900 ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 REMARK 900 RELATED ID: 1D9I RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- REMARK 900 ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1 REMARK 900 RELATED ID: 1DE7 RELATED DB: PDB REMARK 900 INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA- REMARK 900 THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX REMARK 900 RELATED ID: 1DIT RELATED DB: PDB REMARK 900 COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN REMARK 900 RELATED ID: 1DM4 RELATED DB: PDB REMARK 900 SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH REMARK 900 FIBRINOPEPTIDE A (7-16) REMARK 900 RELATED ID: 1DOJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN* RWJ-51438 REMARK 900 COMPLEXAT 1.7 A REMARK 900 RELATED ID: 1DWB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN REMARK 900 (RESIDUES 55 - 65) AND BENZAMIDINE REMARK 900 RELATED ID: 1DWC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN REMARK 900 (RESIDUES 55 - 65) AND MD-805 (ARGATROBAN) REMARK 900 RELATED ID: 1DWD RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN REMARK 900 (RESIDUES 55 - 65) AND NAPAP REMARK 900 RELATED ID: 1DWE RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN REMARK 900 (RESIDUES 55 - 65) AND D-PHE- PRO-ARG-CHLOROMETHYLKETONE REMARK 900 (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE REMARK 900 GROUP REMARK 900 RELATED ID: 1DX5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBIN- THROMBOMODULIN COMPLEX REMARK 900 RELATED ID: 1E0F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ALPHA- THROMBIN-HAEMADIN REMARK 900 COMPLEX: AN EXOSITE II- BINDING INHIBITOR REMARK 900 RELATED ID: 1EB1 RELATED DB: PDB REMARK 900 COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N- METHYL-ARGININE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1EOJ RELATED DB: PDB REMARK 900 DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN REMARK 900 INHIBITORS AND THEIR CRYSTAL STRUCTURES REMARK 900 RELATED ID: 1EOL RELATED DB: PDB REMARK 900 DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN REMARK 900 INHIBITORS AND THEIR CRYSTAL STRUCTURES REMARK 900 RELATED ID: 1FPC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR REMARK 900 HIRUGEN AND ACTIVE SITE INHIBITOR DANSYLARGININE N-(3-ETHYL REMARK 900 -1,5-PENTANEDIYL) AMIDE (DAPA) REMARK 900 RELATED ID: 1FPH RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN AND REMARK 900 FIBRINOPEPTIDE A REMARK 900 RELATED ID: 1G30 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G32 RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G37 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITHBCH REMARK 900 -10556 AND EXOSITE-DIRECTED PEPTIDE REMARK 900 RELATED ID: 1GHV RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHW RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHX RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GHY RELATED DB: PDB REMARK 900 A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- REMARK 900 CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE REMARK 900 RELATED ID: 1GJ4 RELATED DB: PDB REMARK 900 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 REMARK 900 PROTEASE, STRUCTURE-BASED DRUG DESIGN REMARK 900 RELATED ID: 1GJ5 RELATED DB: PDB REMARK 900 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 REMARK 900 PROTEASE, STRUCTURE-BASED DRUG DESIGN REMARK 900 RELATED ID: 1H8D RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE HUMAN ALPHA- THROMBIN COMPLEX WITH A REMARK 900 TRIPEPTIDE PHOSPHONATE INHIBITOR. REMARK 900 RELATED ID: 1H8I RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA- THROMBIN WITH A REMARK 900 TRIPEPTIDE PHOSPHONATE INHIBITOR. REMARK 900 RELATED ID: 1HAG RELATED DB: PDB REMARK 900 PRETHROMBIN2 COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - REMARK 900 64 WITH SULFATO-TYR 63) REMARK 900 RELATED ID: 1HAH RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 REMARK 900 - 64 WITH SULFATO-TYR 63) REMARK 900 RELATED ID: 1HAI RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH D-PHE-PRO- ARG- REMARK 900 CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED REMARK 900 BY A METHYLENE GROUP REMARK 900 RELATED ID: 1HAO RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER REMARK 900 OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON NMR MODEL OF REMARK 900 DEOXYRIBONUCLEIC ACID) REMARK 900 RELATED ID: 1HAP RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER REMARK 900 OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON X-RAY MODEL OF REMARK 900 DEOXYRIBONUCLEIC ACID) REMARK 900 RELATED ID: 1HBT RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM REMARK 900 METHYL KETONE CONTAINING BIVALENT INHIBITOR REMARK 900 RELATED ID: 1HDT RELATED DB: PDB REMARK 900 RELATED ID: 1HGT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUGEN REMARK 900 RELATED ID: 1HLT RELATED DB: PDB REMARK 900 ALPHA THROMBIN COMPLEXED WITH THROMBOMODULIN REMARK 900 (NONDECAPEPTIDE) AND D-PHE-PRO-ARG- CHLOROMETHYLKETONE REMARK 900 (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE REMARK 900 GROUP REMARK 900 RELATED ID: 1HUT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH DEOXYRIBONUCLEIC ACID (5'- REMARK 900 D(GPGPTPTPGPGPTPGPTPGPGPTPTPGPG)-3') AND D-PHE-PRO-ARG- REMARK 900 CHLOROMETHYLKETONE (PPACK ) WITH CHLOROMETHYLKETONE REMARK 900 REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1HXE RELATED DB: PDB REMARK 900 SERINE PROTEASE REMARK 900 RELATED ID: 1HXF RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT REMARK 900 RELATED ID: 1IHS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-2 REMARK 900 RELATED ID: 1IHT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-6 REMARK 900 RELATED ID: 1JMO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II -S195A REMARK 900 THROMBINCOMPLEX REMARK 900 RELATED ID: 1JOU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH REMARK 900 ANUNOCCUPIED ACTIVE SITE REMARK 900 RELATED ID: 1JWT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A REMARK 900 NOVELBICYCLIC LACTAM INHIBITOR REMARK 900 RELATED ID: 1K21 RELATED DB: PDB REMARK 900 HUMAN THROMBIN-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1K22 RELATED DB: PDB REMARK 900 HUMAN THROMBIN-INHIBITOR COMPLEX REMARK 900 RELATED ID: 1KTS RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1KTT RELATED DB: PDB REMARK 900 THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1LHC RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROARG- REMARK 900 OH REMARK 900 RELATED ID: 1LHD RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROLYS- REMARK 900 OH REMARK 900 RELATED ID: 1LHE RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO-N- REMARK 900 BUTYL-AMIDINO-GLYCINE-OH REMARK 900 RELATED ID: 1LHF RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO- REMARK 900 HOMOLYS-OH REMARK 900 RELATED ID: 1LHG RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO- REMARK 900 BOROORNITHINE-OH REMARK 900 RELATED ID: 1MH0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN REMARK 900 RELATED ID: 1MU6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622 REMARK 900 RELATED ID: 1MU8 RELATED DB: PDB REMARK 900 THROMBIN-HIRUGEN_L-378,650 REMARK 900 RELATED ID: 1MUE RELATED DB: PDB REMARK 900 THROMBIN-HIRUGEN-L405,426 REMARK 900 RELATED ID: 1NM6 RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR REMARK 900 AT1.8A REMARK 900 RELATED ID: 1NO9 RELATED DB: PDB REMARK 900 DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS REMARK 900 INCORPORATINGNOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X- REMARK 900 RAYCRYSTALLOGRAPHIC STUDIES. REMARK 900 RELATED ID: 1NRN RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED REMARK 900 PEPTIDE NRS REMARK 900 RELATED ID: 1NRO RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED REMARK 900 PEPTIDE NRP REMARK 900 RELATED ID: 1NRP RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED REMARK 900 PEPTIDE NR'S REMARK 900 RELATED ID: 1NRQ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED REMARK 900 PEPTIDE D-FPR'S REMARK 900 RELATED ID: 1NRR RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED REMARK 900 PEPTIDE XA AND D-PHE-PRO- ARG CHLOROMETHYLKETONE (PPACK) REMARK 900 WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP REMARK 900 RELATED ID: 1NRS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED REMARK 900 PEPTIDE NRP (CLEAVED, FIRST FOUR RESIDUES ONLY) AND HIRUGEN REMARK 900 RELATED ID: 1NT1 RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR REMARK 900 RELATED ID: 1NU7 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-THROMBIN COMPLEX REMARK 900 RELATED ID: 1NU9 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX REMARK 900 RELATED ID: 1NY2 RELATED DB: PDB REMARK 900 HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN REMARK 900 RELATED ID: 1NZQ RELATED DB: PDB REMARK 900 D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR REMARK 900 RELATED ID: 1O0D RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO -ARG- REMARK 900 TYPEINHIBITOR AND A C-TERMINAL HIRUDIN DERIVED EXO- REMARK 900 SITEINHIBITOR REMARK 900 RELATED ID: 1O2G RELATED DB: PDB REMARK 900 ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS REMARK 900 MEDIATINGBINDING OF ACTIVE SITE- DIRECTED SERINE PROTEASE REMARK 900 INHIBITORS REMARK 900 RELATED ID: 1O5G RELATED DB: PDB REMARK 900 DISSECTING AND DESIGNING INHIBITOR SELECTIVITY REMARK 900 DETERMINANTSAT THE S1 SITE USING AN ARTIFICIAL ALA190 REMARK 900 PROTEASE (ALA190UPA) REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- REMARK 900 ALPHA AND HUMAN ALPHA- THROMBIN REMARK 900 RELATED ID: 1OYT RELATED DB: PDB REMARK 900 COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A REMARK 900 DESIGNEDFLUORINATED INHIBITOR REMARK 900 RELATED ID: 1P8V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- REMARK 900 ALPHA AND ALPHA-THROMBIN AT 2.6A REMARK 900 RELATED ID: 1PPB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG REMARK 900 CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED REMARK 900 BY A METHYLENE GROUP REMARK 900 RELATED ID: 1QBV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE- REMARK 900 MIMETIC INHIBITOR REMARK 900 RELATED ID: 1QHR RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ1 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ6 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QJ7 RELATED DB: PDB REMARK 900 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1QUR RELATED DB: PDB REMARK 900 HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE- REMARK 900 BASED SYNTHETIC INHIBITOR REMARK 900 RELATED ID: 1QVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND REMARK 900 THECENTRAL "E" REGION OF FIBRIN REMARK 900 RELATED ID: 1RD3 RELATED DB: PDB REMARK 900 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K REMARK 900 RELATED ID: 1RIW RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOROSCILLARIN REMARK 900 RELATED ID: 1SB1 RELATED DB: PDB REMARK 900 NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4, REMARK 900 5,6,7- TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS REMARK 900 RELATED ID: 1SFQ RELATED DB: PDB REMARK 900 FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK REMARK 900 RELATED ID: 1SG8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN REMARK 900 RELATED ID: 1SGI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN REMARK 900 RELATED ID: 1SHH RELATED DB: PDB REMARK 900 SLOW FORM OF THROMBIN BOUND WITH PPACK REMARK 900 RELATED ID: 1SL3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT REMARK 900 P1HETEROCYCLE-ARYL BASED INHIBITOR REMARK 900 RELATED ID: 1SR5 RELATED DB: PDB REMARK 900 ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY REMARK 900 COMPLEXSTRUCTURE REMARK 900 RELATED ID: 1T4U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND REMARK 900 TOTHROMBIN REMARK 900 RELATED ID: 1T4V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A NOVEL OXYGUANIDINE BOUND REMARK 900 TOTHROMBIN REMARK 900 RELATED ID: 1TA2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1 REMARK 900 RELATED ID: 1TA6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B REMARK 900 RELATED ID: 1TB6 RELATED DB: PDB REMARK 900 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN- THROMBIN- REMARK 900 HEPARINTERNARY COMPLEX REMARK 900 RELATED ID: 1TBZ RELATED DB: PDB REMARK 900 HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N- REMARK 900 [5-(AMINOIMINOMETHYL)AMINO]- 1-{{BENZOTHIAZOLYL)CARBONYL] REMARK 900 BUTYL]-L- PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN REMARK 900 RELATED ID: 1THP RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D- REMARK 900 PHE-PRO-ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 1THR RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULLIN REMARK 900 RELATED ID: 1THS RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH MDL-28050 REMARK 900 RELATED ID: 1TMB RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRUGEN AND CYCLOTHEONAMIDE A REMARK 900 RELATED ID: 1TMT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH CGP 50,856 (D-PHE-PRO-ARG-PRO REMARK 900 -GLY-GLY-GLY-GLY FOLLOWED BY RESIDUES 53 - 65 OF HIRUDIN, REMARK 900 CLEAVED AFTER ARG I 3) REMARK 900 RELATED ID: 1TMU RELATED DB: PDB REMARK 900 ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN (C-TERMINAL REMARK 900 FRAGMENT, RESIDUES 55 - 65) AND PPACK (D-PHE-PRO-ARG- REMARK 900 CHLOROMETHYLKETONE) REMARK 900 RELATED ID: 1TOM RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN REMARK 900 RELATED ID: 1TQ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE POTENT ANTICOAGULANT REMARK 900 THROMBINMUTANT W215A/E217A IN FREE FORM REMARK 900 RELATED ID: 1TQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN REMARK 900 MUTANTW215A/E217A BOUND TO PPACK REMARK 900 RELATED ID: 1TWX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THROMBIN MUTANT D221A/D222K REMARK 900 RELATED ID: 1UMA RELATED DB: PDB REMARK 900 ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N- REMARK 900 DIMETHYLCARBAMOYL)-ALPHA-AZALYSINE REMARK 900 RELATED ID: 1UVS RELATED DB: PDB REMARK 900 BOVINE THROMBIN--BM51.1011 COMPLEX REMARK 900 RELATED ID: 1VR1 RELATED DB: PDB REMARK 900 SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR- 1 REMARK 900 RELATED ID: 1VZQ RELATED DB: PDB REMARK 900 COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165 REMARK 900 RELATED ID: 1W7G RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54- REMARK 900 65) AND L-ARGININE TEMPLATE INHIBITOR CS107 REMARK 900 RELATED ID: 1WAY RELATED DB: PDB REMARK 900 ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1WBG RELATED DB: PDB REMARK 900 ACTIVE SITE THROMBIN INHIBITORS REMARK 900 RELATED ID: 1XM1 RELATED DB: PDB REMARK 900 NONBASIC THROMBIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 1XMN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN REMARK 900 RELATED ID: 1ZRB RELATED DB: PDB REMARK 900 THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B REMARK 900 RELATED ID: 2A0Q RELATED DB: PDB REMARK 900 STRUCTURE OF THROMBIN IN 400 MM POTASSIUM CHLORIDE REMARK 900 RELATED ID: 2BVR RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL REMARK 900 MOLECULES OCCUPYING THE S1 POCKET REMARK 900 RELATED ID: 2BVS RELATED DB: PDB REMARK 900 HUMAN THROMBIN COMPLEXED WITH FRAGMENT-BASED SMALL REMARK 900 MOLECULES OCCUPYING THE S1 POCKET REMARK 900 RELATED ID: 2BVX RELATED DB: PDB REMARK 900 DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS REMARK 900 WITH A SOLUBILIZING REMARK 900 RELATED ID: 2BXU RELATED DB: PDB REMARK 900 DESIGN AND DISCOVERY OF NOVEL, POTENT THROMBIN INHIBITORS REMARK 900 WITH A SOLUBILIZING CATIONIC P1-P2-LINKER REMARK 900 RELATED ID: 2HGT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH HIRULOG I (CLEAVED BETWEEN ARG REMARK 900 3 AND PRO 4) REMARK 900 RELATED ID: 2HNT RELATED DB: PDB REMARK 900 GAMMA-THROMBIN REMARK 900 RELATED ID: 2HPP RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - REMARK 900 CHLOROMETHYLKETONE (PPACK) CHLOROMETHYLKETONE REPLACED BY A REMARK 900 METHYLENE GROUP AND BOVINE PROTHROMBIN FRAGMENT 2 REMARK 900 RELATED ID: 2HPQ RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - REMARK 900 CHLOROMETHYLKETONE (PPACK) CHLOROMETHYLKETONE REPLACED BY A REMARK 900 METHYLENE GROUP AND HUMAN PROTHROMBIN FRAGMENT 2 REMARK 900 RELATED ID: 2THF RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D- REMARK 900 PHE-PRO-ARG- CHLOROMETHYLKETONE REMARK 900 RELATED ID: 3HAT RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND FPAM REMARK 900 (FIBRINOPEPTIDE A MIMIC) REMARK 900 RELATED ID: 3HTC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, REMARK 900 LYS 47) REMARK 900 RELATED ID: 4HTC RELATED DB: PDB REMARK 900 ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, REMARK 900 LYS 47) REMARK 900 RELATED ID: 4THN RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN- HIRUNORM IV REMARK 900 COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE. REMARK 900 RELATED ID: 5GDS RELATED DB: PDB REMARK 900 HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE REMARK 900 OF HUMAN ALPHA-THROMBIN: HIRUNORM V COMPLEX REMARK 900 RELATED ID: 7KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH REMARK 900 SEL2711. REMARK 900 RELATED ID: 8KME RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH REMARK 900 SEL2770. DBREF 2BXT H 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 2BXT I 9 19 UNP P09945 HIRV2_HIRME 61 71 DBREF 2BXT L -5 17 UNP P00734 THRB_HUMAN 328 363 SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 I 11 GLY ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU SEQRES 1 L 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 L 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 L 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG MODRES 2BXT TYS I 18 TYR O-SULFO-L-TYROSINE HET TYS I 18 16 HET C2D H1246 31 HETNAM TYS O-SULFO-L-TYROSINE HETNAM C2D 6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL) HETNAM 2 C2D METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1, HETNAM 3 C2D 4-DIHYDROPYRAZIN-2-OL FORMUL 2 TYS C9 H11 N O6 S FORMUL 4 C2D C22 H31 CL2 N5 O S FORMUL 5 HOH *169(H2 O) HELIX 1 1 ALA H 55 CYS H 58 5 4 HELIX 2 2 PRO H 60B ASP H 60E 5 4 HELIX 3 3 THR H 60I ASN H 62 5 3 HELIX 4 4 ASP H 125 LEU H 130 1 9 HELIX 5 5 GLU H 164 SER H 171 1 8 HELIX 6 6 LYS H 185 GLY H 186C 5 5 HELIX 7 7 LEU H 234 PHE H 245 1 12 HELIX 8 8 PRO I 15 LEU I 19 5 5 HELIX 9 9 PHE L 7 SER L 11 5 5 HELIX 10 10 THR L 14B TYR L 14J 1 9 SHEET 1 HA 7 SER H 20 ASP H 21 0 SHEET 2 HA 7 GLN H 156 PRO H 161 -1 O VAL H 157 N SER H 20 SHEET 3 HA 7 LYS H 135 GLY H 140 -1 O GLY H 136 N LEU H 160 SHEET 4 HA 7 PRO H 198 LYS H 202 -1 O PRO H 198 N THR H 139 SHEET 5 HA 7 TRP H 207 TRP H 215 -1 O TYR H 208 N MET H 201 SHEET 6 HA 7 GLY H 226 HIS H 230 -1 O PHE H 227 N SER H 214 SHEET 7 HA 7 MET H 180 ALA H 183 -1 O PHE H 181 N TYR H 228 SHEET 1 HB 7 GLN H 30 ARG H 35 0 SHEET 2 HB 7 GLU H 39 LEU H 46 -1 O GLU H 39 N ARG H 35 SHEET 3 HB 7 TRP H 51 THR H 54 -1 O LEU H 53 N SER H 45 SHEET 4 HB 7 ALA H 104 LEU H 108 -1 O ALA H 104 N THR H 54 SHEET 5 HB 7 LYS H 81 ILE H 90 -1 N GLU H 86 O LYS H 107 SHEET 6 HB 7 LEU H 64 ILE H 68 -1 O LEU H 64 N LEU H 85 SHEET 7 HB 7 GLN H 30 ARG H 35 -1 O MET H 32 N ARG H 67 SHEET 1 HC 2 LEU H 60 TYR H 60A 0 SHEET 2 HC 2 LYS H 60F ASN H 60G-1 O LYS H 60F N TYR H 60A SSBOND 1 CYS H 42 CYS H 58 1555 1555 2.01 SSBOND 2 CYS H 122 CYS L 1 1555 1555 2.05 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.01 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.04 LINK C GLU I 17 N TYS I 18 1555 1555 1.33 LINK C TYS I 18 N LEU I 19 1555 1555 1.33 CISPEP 1 SER H 37 PRO H 37A 0 -4.04 SITE 1 AC1 18 HIS H 57 TYR H 60A GLU H 97A ILE H 174 SITE 2 AC1 18 ASP H 189 ALA H 190 GLU H 192 SER H 195 SITE 3 AC1 18 VAL H 213 SER H 214 TRP H 215 GLY H 216 SITE 4 AC1 18 GLU H 217 GLY H 219 CYS H 220 GLY H 226 SITE 5 AC1 18 PHE H 227 HOH H2145 SITE 1 AC2 20 PHE H 34 GLN H 38 LEU H 40 LEU H 65 SITE 2 AC2 20 ARG H 73 THR H 74 ARG H 75 TYR H 76 SITE 3 AC2 20 GLU H 80 LYS H 81 ILE H 82 HOH H2032 SITE 4 AC2 20 HOH H2036 HOH I2001 HOH I2002 HOH I2003 SITE 5 AC2 20 HOH I2004 HOH I2005 HOH I2007 HOH I2008 CRYST1 70.505 71.917 72.522 90.00 100.35 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014183 0.000000 0.002590 0.00000 SCALE2 0.000000 0.013905 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014017 0.00000 MASTER 798 0 2 10 16 0 10 6 0 0 0 24 END